Hoppa direkt till innehållet

Avhandlingar 1992-2016


Holmgren A. Metabolic risk markers and relative survival in patients with aortic stenosis requiring surgery. Umeå: Umeå University; 2019.


Strömbäck U. The second myocardial infarction. A known but different experience. Luleå: Luleå University of Technology; 2018.

Ljungberg J. Cardiovascular risk factors in Aortic Stenosis. Umeå: Umeå University; 2018.

Myte R. Metabolic Risk Factors and Molecular Subtypes of Colorectal Cancer. Umeå: Umeå University; 2018


Pennlert J. Recurrent stroke. Risk factors, prevention and prognosis. Umeå: Umeå University; 2016.

Rautio A. Diabetes mellitus and cardiovascular risk. Epidemiology, etiology and intervention. Umeå: Umeå University; 2016


Waller G. Self-rated health. From epidemiology to patient encounter. Umeå: Umeå University; 2015.

Hellström Ängerud K. Symptoms and care seeking behavior during myocardial infarction in patients with diabetes. Umeå: Umeå University; 2015.


Jacobson S. Severe sepsis. Epidemiology and sex-related differences in inflammatory markers. Umeå: Umeå University; 2014.

Forslund A-S. A second chance at life. A study about people suffering out-of-hospital cardiac arrest. Luleå: Luleå University of Technology; 2014.

Hernestål Boman J. Fibrinolytic factors in relation to anthropometry and incident type 2 diabetes. Umeå: Umeå university; 2014.


49. Nilsson LM. Sami lifestyle and health: epidemiological studies from northern Sweden. Umeå: Umeå University; 2012.


48. Lilja M. Trends in obesity and type 2 diabetes; ethnic aspects and links to adipokines. Umeå: Umeå University; 2011.

47. Isaksson R-M. Symptoms, prehospital delay and long-term survival in men vs. women with myocardial infarction. A combined register and qualitative study. Umeå: Umeå University; 2011.


46 Ekblom K. Oxidants and antioxidants in cardiovascular disease. Umeå: Umeå University; 2010.

45. Lindholm Å. Metabolic Aspects in the Polycystic Ovary Syndrome. Uppsala: Uppsala University; 2010.

44. Eriksson M. Adipocyte-derived hormones and cardiovascular disease. Umeå: Umeå University; 2010.

43. Wennberg M. Biomarkers of fish consumption and risk of stroke or myocardial infarction. Umeå: Umeå University; 2010.

42. Janunger T. The genetic contribution to stroke in northern Sweden. Umeå: Umeå University; 2010.

41. Andersson J. Inflammation and lifestyle in cardiovascular medicine. Umeå: Umeå University; 2010.


40. Wennberg P. Beyond the established risk factors of myocardial infarction : lifestyle factors and novel biomarkers. Umeå: Umeå University; 2009.


39. Södergren A. Epidemiological and pathogenic aspects on cardiovascular disease in rheumatoid arthritis. Umeå: Umeå University; 2008.

38. Nordfjäll K. Telomere length - inheritance pattern and role as a biomarker. Umeå: Umeå University; 2008.


37. Strand M. Estrogen signaling in stroke : genetic and experimental studies. Umeå: Umeå University; 2007.

36. Löfmark U. Stroke with a focus in the elderly: from a gender and socioeconomic perspective. Umeå: Umeå University; 2007.

35. Krachler B. Diet and Cardiometabolic Disease: Dietary trends and the impact of diet on diabetes and cardiovascular disease. Umeå: Umeå University; 2007.


34. Nordin M. Low social support and disturbed sleep : epidemiological and psychological perspectives. Umeå: Umeå University; 2006.

33. Van Guelpen B. Folate in cancer and cardiovascular disease: prospective studies from the population-based northern Sweden health and disease study. Umeå: Umeå University; 2006.

32. Nilsson Ardnor S. Genetic studies of stroke in Northern Sweden. Umeå: Umeå University; 2006.

31. Wiklund P. Genetic aspects of stroke: association and linkage studies in a northern Swedish population. Umeå: Umeå University; 2005.


30. Hultdin J. Homocysteine in cardiovascular disease with special reference to longitudinal changes. Umeå: Umeå University; 2005.

29. Thøgersen A. Risk markers for a first myocardial infarction. Umeå: Umeå University; 2005.


28. Emmelin M. Self-rated health in public health evaluation. Umeå: Umeå University; 2004.

27. Held M. Epidemiological studies of helicobacter pylori and its relation to cancer and precancerous lesions in the upper gastrointestinal tract. Stockholm: Karolinska Institutet; 2004.

26. Rönnbäck B-I. Are uncertain uncertainties useful? Towards improved quality assessment of spatial data. Luleå: Luleå University of Technology; 2004.


25. Persson M. Bring hypertension guidelines into play: Guideline-based decision support system for drug treatment of hypertension and epidemiological aspects of hypertension guidelines. Umeå: Umeå University; 2003.


24. Cvetkovic' J. Immune mechanisms in atherosclerotic vascular disease. Stockholm: Karolinska Institutet; 2002.

23. Ladenvall P. Genetic variation at the human tissue-type plasminogen activator locus. Göteborg: University of Gothenburg; 2002.

22. Nilsson B. Vad betyder känsla av sammanhang i våra liv: Aspekter på stabilitet, kön, hälsa och psykosociala faktorer. Umeå: Umeå University; 2002.

21. Rask E. Neuroendocrine studies in obesity and insulin resistance (Dissertation). Umeå: Umeå University; 2002.

20. Johansson L. Hemostatic factors in cardiovascular disease with special reference to stroke. Umeå: Umeå university; 2002.


19. Ahlbeck-Glader C. Studies on lipoprotein (a) in relation to survival and to interaction with Chlamydia pneumoniae in atherosclerotic disease. Umeå: Umeå University; 2001.

18. Ahmed E. Immune mechanisms in atherosclerosis.Stockholm: Karolinska Institutet; 2001.

17. Ivarsson A. On the multifactorial etiology of celiac disease: An epidemiological approach to the Swedish epidemic. Umeå, Umeå University; 2001.

16. Janhsen K. Joint analysis of the MONICA optional study on drugs: Antihypertensive drug treatment in an international comparison and its relations to hypertension control and myocardial infarction. Bremen: University of Bremen; 2001.


15. Lundberg V. Women versus men with myocardial infarction: sex differences in risk factors, management and outcome. Umeå: Umeå University, 2000.


14. Mogren I. Reproductive factors' impact on the health of mother and offspring: An epidemiological study. Umeå: Umeå University; 1999.

13. Nilsson L Regulation of plasminogen activator inhibitor-1: Role of triglyceride-rich lipoproteins, fatty acids and fibrate compounds. Stockholm: Karolinska Institutet; 1999.

12. Peltonen M. Trends and determinants in cardiovscular disease in Sweden. Umeå: Umeå University; 1999.

11. Söderberg S. Leptin - a cardiovascular riskmarker. Umeå: Umeå University; 1999.


10. Lindahl B. Lifestyle and health. The role of insulin resistance syndrome in cardiovascular disease and diabetes. The effects of lifestyle intervention.Umeå: Umeå University; 1998.

9. Kristensen Tranberg B. Stroke in young adults in Northern Sweden. Umeå: Umeå University; 1998.


8. Ahlm C. Distribution of puumala virus in Sweden. Umeå: Umeå University; 1997.

7. Mooe T. Left ventricular thrombus and stroke after acute myocardial infarction. Umeå: Umeå University; 1997.

6. Weinehall L. Partnership for health: On the role of primary health care in community intervention programme. Umeå: Umeå University; 1997.


5. Stegmayr B. Stroke in the Community. Studies on Risk Factors, Incidence, Case Fatality, Severity and Secular Trends in the Northern Sweden MONICA Project, with Multinational Comparisons. Umeå: Umeå University; 1996.


4. Eliasson M. The epidemiology of fibrinogen and fibrinolysis. Umeå, Umeå University; 1995.

3. Tidehag P. Iron absorption and iron status related to diet: An experimental and epidemiological study. Umeå: Umeå University; 1995.


2. Slunga L. Serum lipoprotein (a) in relation to ischemic heart disease and associated risk factors. Umeå: Umeå University; 1993.


1. Nylander PO. Ethnic heterogeneity of the North-Swedish population: Its origin and medical consequences. Umeå: Umeå University; 1992.